On this episode we are joined by psychopharmacologist, psychiatrist, and author Julie Holland MD. Julie and Drew discuss the importance of psychedelics for healing, unpacking the prevalent role it can play in psychotherapy and treating trauma. Julie also speaks about the danger of improperly used substances and why integration is essential for these tools. From a therapists point of view, they tackle common arguments related to touch in therapy, spirituality, and mixing meds with psychedelics. This is a great discussion for anyone wanting a closer look at the future of psychedelic therapy.
Show Notes:
0:00 Intro
1:17 How Julie Became Interested in Psychedelics
5:35 Speaking to Adolescence About Drugs
8:45 The Danger of Street Drugs
10:55 Why Integration is Essential
13:35 The Risk of Too Much Neuroplasticity
18:04 How Trauma is Stored in the Body
21:45 Is Touch in Psychotherapy Okay?
23:45 Are Psychedelics a Miracle Solution
26:48 Addressing the Argument of SSRIs
28:10 Should Psychedelics be Limited to Therapy?
32:48 What Therapists Should be Thinking About
38:31 Mixing Spirituality with Medicine
41:15 This is Changing Everything
44:03 How to Extend Accessibility
46:40 Guiding a Session Empathically
47:50 Scalability & Group Sessions
52:08 Do You Need to Stop Your Meds?
57:17 Ketamine & Paving the Way for the Future
1:00:00 Treating Alcoholism with Ketamine
1:00:54 Giving Patients Options
1:04:10 Nutrition & Emotional Eating
1:09:20 The Risk Factors of Psychedelics
1:16:49 Julie’s Personal Wellness Practices
1:24:31 Bringing it All Together
1:27:50 Conclusion
Julie Holland is an American psychopharmacologist, psychiatrist, and author. She is the author of five books, including Weekends at Bellevue: Nine Years on the Night Shift at the Psych ER, a memoir documenting her experience as the weekend head of the psychiatric emergency room at Bellevue Hospital in New York City. An advocate for the appropriate use of consciousness expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication.
